Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from AnaptysBio, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
FAQ
- What is AnaptysBio, Inc.'s EBIT?
- AnaptysBio, Inc. (ANAB) reported EBIT of -$34.64M in Q1 2026.
- How has AnaptysBio, Inc.'s EBIT changed year-over-year?
- AnaptysBio, Inc.'s EBIT decreased by 25.8% year-over-year, from -$27.54M to -$34.64M.
- What is the long-term trend for AnaptysBio, Inc.'s EBIT?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s EBIT has grown at a -4.2% compound annual growth rate (CAGR), from -$56.81M to $47.9M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about AnaptysBio, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude